Interleukin 6 knockout prevents angiotensin II hypertension

Role of renal vasoconstriction and janus kinase 2/signal transducer and activator of transcription 3 activation

Michael W Brands, Amy K L Banes-Berceli, Edward W. Inscho, Hind Al-Azawi, Ashlyn J. Allen, Hicham Labazi

Research output: Contribution to journalArticle

83 Citations (Scopus)

Abstract

Chronic angiotensin II (Ang II) infusion stimulates interleukin (IL) 6 release, and we and others have shown that preventing the increase in IL-6 significantly attenuates Ang II hypertension. This study measured renal blood flow (RBF) chronically, using Transonic flow probes in wild-type (WT) and IL-6 knockout (KO) mice, to determine the role of RBF regulation in that response. Ang II infusion at 200, 800, and 3600 ng/kg per minute caused a dose-dependent decrease in RBF in WT mice, and the response at 800 ng/kg per minute was compared between WT and IL-6 KO mice. Ang II infusion increased plasma IL-6 concentration in WT mice and increased mean arterial pressure (19 h/d with telemetry) from 113±4 to 149±4 mm Hg (Δ36 mm Hg) over the 7-day infusion period, and that effect was blocked in IL-6 KO mice (119±7 to 126±7 mm Hg). RBF decreased to an average of 61±8% of control over the 7-day period (control: 0.86±0.02 mL/min) in the WT mice; however, the average decrease to 72±6% of control (control: 0.88±0.02 mL/min) in the KO mice was not significantly different. There also was no difference in afferent arteriolar constriction by Ang II in blood-perfused juxtamedullary nephrons in WT versus KO mice. Phosphorylation of janus kinase 2 and signal transducer and activator of transcription 3 in renal cortex homogenates increased significantly in Ang II-infused WT mice, and that effect was prevented completely in Ang II-infused IL-6 KO mice. These data suggest that IL-6-dependent activation of the renal janus kinase 2/signal transducer and activator of transcription 3 pathway plays a role in Ang II hypertension but not by mediating the effect of Ang II to decrease total RBF.

Original languageEnglish (US)
Pages (from-to)879-884
Number of pages6
JournalHypertension
Volume56
Issue number5
DOIs
StatePublished - Nov 1 2010

Fingerprint

Janus Kinase 2
STAT3 Transcription Factor
Renal Hypertension
Vasoconstriction
Angiotensin II
Transcriptional Activation
Interleukin-6
Knockout Mice
Renal Circulation
Hypertension
Kidney
Telemetry
Nephrons
Constriction
Arterial Pressure
Phosphorylation

Keywords

  • JAK2
  • STAT3
  • angiotensin II
  • blood pressure
  • interleukin 6
  • renal blood flow

ASJC Scopus subject areas

  • Internal Medicine

Cite this

Interleukin 6 knockout prevents angiotensin II hypertension : Role of renal vasoconstriction and janus kinase 2/signal transducer and activator of transcription 3 activation. / Brands, Michael W; Banes-Berceli, Amy K L; Inscho, Edward W.; Al-Azawi, Hind; Allen, Ashlyn J.; Labazi, Hicham.

In: Hypertension, Vol. 56, No. 5, 01.11.2010, p. 879-884.

Research output: Contribution to journalArticle

Brands, Michael W ; Banes-Berceli, Amy K L ; Inscho, Edward W. ; Al-Azawi, Hind ; Allen, Ashlyn J. ; Labazi, Hicham. / Interleukin 6 knockout prevents angiotensin II hypertension : Role of renal vasoconstriction and janus kinase 2/signal transducer and activator of transcription 3 activation. In: Hypertension. 2010 ; Vol. 56, No. 5. pp. 879-884.
@article{24ef4386fe4c40ecad2bc3f6359124f0,
title = "Interleukin 6 knockout prevents angiotensin II hypertension: Role of renal vasoconstriction and janus kinase 2/signal transducer and activator of transcription 3 activation",
abstract = "Chronic angiotensin II (Ang II) infusion stimulates interleukin (IL) 6 release, and we and others have shown that preventing the increase in IL-6 significantly attenuates Ang II hypertension. This study measured renal blood flow (RBF) chronically, using Transonic flow probes in wild-type (WT) and IL-6 knockout (KO) mice, to determine the role of RBF regulation in that response. Ang II infusion at 200, 800, and 3600 ng/kg per minute caused a dose-dependent decrease in RBF in WT mice, and the response at 800 ng/kg per minute was compared between WT and IL-6 KO mice. Ang II infusion increased plasma IL-6 concentration in WT mice and increased mean arterial pressure (19 h/d with telemetry) from 113±4 to 149±4 mm Hg (Δ36 mm Hg) over the 7-day infusion period, and that effect was blocked in IL-6 KO mice (119±7 to 126±7 mm Hg). RBF decreased to an average of 61±8{\%} of control over the 7-day period (control: 0.86±0.02 mL/min) in the WT mice; however, the average decrease to 72±6{\%} of control (control: 0.88±0.02 mL/min) in the KO mice was not significantly different. There also was no difference in afferent arteriolar constriction by Ang II in blood-perfused juxtamedullary nephrons in WT versus KO mice. Phosphorylation of janus kinase 2 and signal transducer and activator of transcription 3 in renal cortex homogenates increased significantly in Ang II-infused WT mice, and that effect was prevented completely in Ang II-infused IL-6 KO mice. These data suggest that IL-6-dependent activation of the renal janus kinase 2/signal transducer and activator of transcription 3 pathway plays a role in Ang II hypertension but not by mediating the effect of Ang II to decrease total RBF.",
keywords = "JAK2, STAT3, angiotensin II, blood pressure, interleukin 6, renal blood flow",
author = "Brands, {Michael W} and Banes-Berceli, {Amy K L} and Inscho, {Edward W.} and Hind Al-Azawi and Allen, {Ashlyn J.} and Hicham Labazi",
year = "2010",
month = "11",
day = "1",
doi = "10.1161/HYPERTENSIONAHA.110.158071",
language = "English (US)",
volume = "56",
pages = "879--884",
journal = "Hypertension",
issn = "0194-911X",
publisher = "Lippincott Williams and Wilkins",
number = "5",

}

TY - JOUR

T1 - Interleukin 6 knockout prevents angiotensin II hypertension

T2 - Role of renal vasoconstriction and janus kinase 2/signal transducer and activator of transcription 3 activation

AU - Brands, Michael W

AU - Banes-Berceli, Amy K L

AU - Inscho, Edward W.

AU - Al-Azawi, Hind

AU - Allen, Ashlyn J.

AU - Labazi, Hicham

PY - 2010/11/1

Y1 - 2010/11/1

N2 - Chronic angiotensin II (Ang II) infusion stimulates interleukin (IL) 6 release, and we and others have shown that preventing the increase in IL-6 significantly attenuates Ang II hypertension. This study measured renal blood flow (RBF) chronically, using Transonic flow probes in wild-type (WT) and IL-6 knockout (KO) mice, to determine the role of RBF regulation in that response. Ang II infusion at 200, 800, and 3600 ng/kg per minute caused a dose-dependent decrease in RBF in WT mice, and the response at 800 ng/kg per minute was compared between WT and IL-6 KO mice. Ang II infusion increased plasma IL-6 concentration in WT mice and increased mean arterial pressure (19 h/d with telemetry) from 113±4 to 149±4 mm Hg (Δ36 mm Hg) over the 7-day infusion period, and that effect was blocked in IL-6 KO mice (119±7 to 126±7 mm Hg). RBF decreased to an average of 61±8% of control over the 7-day period (control: 0.86±0.02 mL/min) in the WT mice; however, the average decrease to 72±6% of control (control: 0.88±0.02 mL/min) in the KO mice was not significantly different. There also was no difference in afferent arteriolar constriction by Ang II in blood-perfused juxtamedullary nephrons in WT versus KO mice. Phosphorylation of janus kinase 2 and signal transducer and activator of transcription 3 in renal cortex homogenates increased significantly in Ang II-infused WT mice, and that effect was prevented completely in Ang II-infused IL-6 KO mice. These data suggest that IL-6-dependent activation of the renal janus kinase 2/signal transducer and activator of transcription 3 pathway plays a role in Ang II hypertension but not by mediating the effect of Ang II to decrease total RBF.

AB - Chronic angiotensin II (Ang II) infusion stimulates interleukin (IL) 6 release, and we and others have shown that preventing the increase in IL-6 significantly attenuates Ang II hypertension. This study measured renal blood flow (RBF) chronically, using Transonic flow probes in wild-type (WT) and IL-6 knockout (KO) mice, to determine the role of RBF regulation in that response. Ang II infusion at 200, 800, and 3600 ng/kg per minute caused a dose-dependent decrease in RBF in WT mice, and the response at 800 ng/kg per minute was compared between WT and IL-6 KO mice. Ang II infusion increased plasma IL-6 concentration in WT mice and increased mean arterial pressure (19 h/d with telemetry) from 113±4 to 149±4 mm Hg (Δ36 mm Hg) over the 7-day infusion period, and that effect was blocked in IL-6 KO mice (119±7 to 126±7 mm Hg). RBF decreased to an average of 61±8% of control over the 7-day period (control: 0.86±0.02 mL/min) in the WT mice; however, the average decrease to 72±6% of control (control: 0.88±0.02 mL/min) in the KO mice was not significantly different. There also was no difference in afferent arteriolar constriction by Ang II in blood-perfused juxtamedullary nephrons in WT versus KO mice. Phosphorylation of janus kinase 2 and signal transducer and activator of transcription 3 in renal cortex homogenates increased significantly in Ang II-infused WT mice, and that effect was prevented completely in Ang II-infused IL-6 KO mice. These data suggest that IL-6-dependent activation of the renal janus kinase 2/signal transducer and activator of transcription 3 pathway plays a role in Ang II hypertension but not by mediating the effect of Ang II to decrease total RBF.

KW - JAK2

KW - STAT3

KW - angiotensin II

KW - blood pressure

KW - interleukin 6

KW - renal blood flow

UR - http://www.scopus.com/inward/record.url?scp=78149243218&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78149243218&partnerID=8YFLogxK

U2 - 10.1161/HYPERTENSIONAHA.110.158071

DO - 10.1161/HYPERTENSIONAHA.110.158071

M3 - Article

VL - 56

SP - 879

EP - 884

JO - Hypertension

JF - Hypertension

SN - 0194-911X

IS - 5

ER -